Drug Discovery · Medfield, MA · Founded 2020 · Privately Held (backing)
Developer of respiratory drugs designed for novel therapeutics for patients affected by intractable diseases. Kinaset Therapeutics is based in Medfield, MA and was founded in 2020. It was valued at $186 million at its later-stage round in Jan 2026, the last priced event on record. It has raised $143 million across 3 recorded rounds; the latest was a $103 million Series B in Jan 2026.
PMV mark · valuation
$186.0M
Oct 2026
Priced at
its later-stage round
Jan 2026
Total raised
$143.0M
Last round
Later Stage VC (Series B)
Jan 2026
Cap table — not yet on record
Kinaset Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Kinaset Therapeutics with a free account
·The complete investor list: 12 names
·Watch Kinaset Therapeutics: the Monday email on marks, rounds and moves
Where does Kinaset Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Kinaset Therapeutics's 3 recorded funding rounds.
